Mesenteric Vascular Insufficiency¶
Chapter 340 | Mesenteric Vascular Insufficiency
KEY CLINICAL POINTS¶
- Mesenteric ischemia is classified into chronic (CMI) and acute (AMI) forms, with CMI linked to atherosclerosis and AMI often due to embolism or thrombosis.
- CMI presents with postprandial epigastric pain, while AMI is a surgical emergency with severe abdominal pain disproportionate to physical findings.
- Diagnosis requires imaging (CT angiography, mesenteric duplex scan) and prompt intervention to prevent bowel necrosis.
- Treatment options include endovascular revascularization, open surgery, or hybrid approaches, depending on etiology and patient comorbidities.
- Nonocclusive mesenteric ischemia is associated with hemodynamic instability and cardiovascular surgery, requiring aggressive resuscitation.
1. DEFINITION & OVERVIEW¶
Mesenteric vascular insufficiency refers to inadequate blood flow to the intestines, leading to ischemia. It encompasses chronic mesenteric ischemia (CMI) and acute mesenteric ischemia (AMI), with distinct etiologies and management strategies.
Table 340-1 Overview of the Management of Acute Intestinal Ischemia¶
| CONDITION | KEY TO EARLY DIAGNOSIS | TREATMENT OF UNDERLYING CAUSE | TREATMENT OF SPECIFIC LESION | TREATMENT OF SYSTEMIC CONSEQUENCE |
|---|---|---|---|---|
| Arterio-occlusive mesenteric ischemia | Computed tomography angiography (CTA) | Anticoagulation, Cardioversion | Laparotomy, Embolectomy | Anticoagulation, Resuscitation, Broad-spectrum antibiotics |
| Arterio-occlusive mesenteric ischemia | Duplex ultrasound | Anticoagulation | Endovascular approach: thrombolysis, angioplasty, stenting | Anticoagulation, Resuscitation, Broad-spectrum antibiotics |
| Mesenteric venous thrombosis | CTA with venous phase | Anticoagulation | Anticoagulation, Hypercoagulable workup | Resuscitation, Support cardiac output, Avoid vasoconstrictors |
| Nonocclusive mesenteric ischemia | CT | Resuscitation, Support cardiac output | Intraarterial vasodilators | Resuscitation, Broad-spectrum antibiotics, Support cardiac output |
1.1 Classification¶
Mesenteric ischemia is categorized into three types: (1) arterio-occlusive (CMI), (2) nonocclusive, and (3) venous thrombosis. CMI is due to atherosclerosis, while AMI is often embolic or thrombotic.
1.2 Pathophysiology¶
Ischemia results from imbalance between oxygen supply and demand. CMI involves atherosclerotic narrowing of the superior mesenteric artery (SMA) or celiac artery. AMI is caused by embolism or thrombosis in mesenteric vessels.
2. EPIDEMIOLOGY¶
Mesenteric ischemia affects 2–3 per 100,000, with increasing incidence in the elderly. AMI has a high mortality rate (50–80%), while CMI is more common in patients over 50 with atherosclerosis.
2.1 Risk Factors¶
Atherosclerosis, atrial fibrillation, recent myocardial infarction, infective endocarditis, and use of vasoconstrictive agents increase risk. Nonocclusive ischemia is common in patients undergoing cardiovascular surgery.
2.2 Demographics¶
CMI predominantly affects older adults with atherosclerosis. AMI is more common in patients with preexisting vascular disease or recent cardiac events.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Ischemia arises from occlusive or nonocclusive mechanisms. CMI is due to atherosclerosis, while AMI is often embolic or thrombotic. Nonocclusive ischemia results from hemodynamic instability.
3.1 Arterio-Occlusive Causes¶
Atherosclerosis narrows the SMA or celiac artery, leading to chronic ischemia. Embolism (50% of AMI cases) originates from the heart, often due to atrial fibrillation or recent myocardial infarction.
3.2 Nonocclusive Causes¶
Hemodynamic instability (e.g., shock, hypovolemia) causes disproportionate vasoconstriction. Common in patients with preexisting atherosclerosis undergoing cardiovascular surgery.
3.3 Venous Thrombosis¶
Hypercoagulable states (e.g., factor V Leiden, antiphospholipid syndrome) or malignancy cause mesenteric vein thrombosis. Chronic diarrhea may accompany venous thrombosis.
4. CLINICAL FEATURES¶
CMI presents with postprandial pain and fear of eating. AMI is characterized by severe, nonremitting abdominal pain disproportionate to physical findings. Early signs include nausea, vomiting, and hematochezia.
4.1 CMI Presentation¶
Insidious onset of epigastric pain after meals, weight loss, and fear of eating. Chronic fissures may mimic CMI but are distinct entities.
4.2 AMI Presentation¶
Severe, acute pain out of proportion to findings. Later stages show peritonitis, cardiovascular collapse, and signs of bowel necrosis.
5. DIFFERENTIAL DIAGNOSIS¶
Distinguish mesenteric ischemia from other causes of abdominal pain, including appendicitis, diverticulitis, and bowel obstruction. Consider Crohn’s disease, malignancy, or infections in atypical presentations.
5.1 Red Flags¶
Lateral anal fissures, unexplained weight loss, or systemic symptoms (e.g., fever) suggest underlying conditions like Crohn’s disease or malignancy.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis relies on imaging (CT angiography, mesenteric duplex scan) and clinical evaluation. Early detection is critical to prevent bowel necrosis.
6.1 Imaging¶
CT angiography with 1-mm cuts is the gold standard for detecting embolic or thrombotic occlusions. Mesenteric duplex scan has high sensitivity/specificity for CMI.
6.2 Laboratory Tests¶
Lactate levels, complete blood count, and coagulation profile help assess severity. Hypercoagulable workup is essential for venous thrombosis.
7. MANAGEMENT & TREATMENT¶
Treatment varies by etiology: anticoagulation for CMI, endovascular or surgical revascularization for AMI, and vasodilators for nonocclusive ischemia. Prompt intervention is critical.
7.1 Medical Therapy¶
Anticoagulation (heparin), antiplatelet agents, and lipid-lowering drugs for CMI. Vasodilators (e.g., papaverine) for nonocclusive ischemia.
7.2 Endovascular Approaches¶
Stenting, angioplasty, or thrombolysis for localized stenosis. Preferred for short-segment disease with minimal calcification.
7.3 Surgical Intervention¶
Laparotomy with resection of nonviable bowel and restoration of blood flow. Retrograde open mesenteric stenting (ROMS) combines endovascular and open techniques.
8. PROGNOSIS & COMPLICATIONS¶
AMI has high mortality (50–80%) without prompt intervention. Complications include bowel necrosis, sepsis, and long-term bowel dysfunction. CMI outcomes depend on timely revascularization.
8.1 Mortality¶
AMI mortality is >50% if untreated. Early diagnosis and revascularization improve survival rates.
8.2 Long-Term Outcomes¶
CMI patients require lifelong management of atherosclerosis. Nonocclusive ischemia may resolve with hemodynamic stabilization.
9. SPECIAL CONSIDERATIONS¶
Pregnancy and pediatric cases are rare. In elderly patients, comorbidities like aortic insufficiency or renal disease complicate management. Anticoagulation must be balanced against bleeding risks.
9.1 Anticoagulation Risks¶
Heparin is preferred for AMI, but bleeding risks must be weighed against mortality. Avoid vasoconstrictive agents in nonocclusive ischemia.
10. KEY POINTS & CLINICAL PEARLS¶
- CMI is chronic, AMI is acute and life-threatening. 2. CT angiography is the gold standard for diagnosis. 3. Endovascular therapy is first-line for localized stenosis. 4. Prompt surgical intervention is critical for AMI. 5. Nonocclusive ischemia requires hemodynamic support and vasodilators.